Hahn Mark W 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Hahn Mark W（CIK 1408502）在 2 家公司共报告 20 笔 SEC Form 4 内部人交易（最近一笔 2026-05-18）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | 董事 | 卖出 | 10,046 | $0 |
| 2025-10-14 | SOLENO THERAPEUTICS INC (SLNO) | 董事 | 买入 | 10,046 | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 11.3M | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Chief Financial Officer | 买入 | 3.3M | $0 |
| 2025-10-08 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 3.3M | $0 |
| 2025-09-03 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 1.2M | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | 买入 | 255,696 | $0 |
| 2025-08-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 208,912 | $2.7M |
| 2025-07-09 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 90,320 | $1.0M |
| 2025-07-09 | Verona Pharma plc (VRNA) | Chief Financial Officer | 买入 | 229,512 | $0 |
| 2025-06-13 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 400,000 | $4.6M |
| 2025-05-29 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 32,432 | $309,077 |
| 2025-05-29 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 162,704 | $1.5M |
| 2025-05-29 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 204,864 | $1.9M |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 108,272 | $969,034 |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | 买入 | 200,000 | $0 |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 78,736 | $704,687 |
| 2025-05-05 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 400,000 | $3.6M |
| 2025-05-01 | Verona Pharma plc (VRNA) | Chief Financial Officer | 买入 | 229,512 | $0 |
| 2025-05-01 | Verona Pharma plc (VRNA) | Chief Financial Officer | 卖出 | 90,360 | $811,433 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18